Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168256748> ?p ?o ?g. }
- W2168256748 endingPage "755" @default.
- W2168256748 startingPage "749" @default.
- W2168256748 abstract "Background Chronic plaque psoriasis is associated with obesity, which is a metabolic and inflammatory disorder. Adipokines are involved in the pathogenesis of psoriasis and they are biomarkers of obesity‐related inflammation. Objectives To measure serum adipokines in patients with chronic plaque psoriasis treated with infliximab. Methods Serum levels of chemerin, resistin, visfatin, C‐reactive protein (CRP), lipids, glycaemia and liver enzymes were measured in 40 patients with psoriasis and 40 controls matched by age, sex and body mass index (BMI). Adipokines were measured at baseline and after 2–12 months of treatment with infliximab 5 mg kg−1. Results At baseline, levels of chemerin (195·9 ± 48·5 vs. 145·6 ± 27·1 ng mL−1), resistin (2·03 ± 0·9 vs. 1·4 ± 0·5 ng mL−1) and CRP (5·5 ± 7·3 vs. 1·9 ± 4·4 mg L−1) were higher (P <0·01) in patients with psoriasis compared with controls. Psoriasis was associated with elevated chemerin level independently of age, sex, BMI and levels of cholesterol and triglycerides. Chemerin was linearly correlated to CRP (r =0·4, P =0·01) and resistin (r =0·3, P =0·01). Chemerin levels were higher in patients affected by psoriatic arthritis than in patients with psoriasis without arthritis (195·5 ± 49·1 vs. 158·1 ± 37·5 ng mL−1, P =0·01). After 2 months of infliximab treatment a significant reduction of chemerin, resistin and CRP levels was observed. Conclusions Patients with psoriasis have higher blood levels of adipokines, which normalize during therapy with infliximab. Whether this reduction is a direct effect of infliximab or secondary to a reduction of inflammation should be further investigated." @default.
- W2168256748 created "2016-06-24" @default.
- W2168256748 creator A5016818733 @default.
- W2168256748 creator A5042034018 @default.
- W2168256748 creator A5073522064 @default.
- W2168256748 creator A5080357338 @default.
- W2168256748 creator A5087192032 @default.
- W2168256748 creator A5090979652 @default.
- W2168256748 date "2013-02-27" @default.
- W2168256748 modified "2023-09-23" @default.
- W2168256748 title "Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab" @default.
- W2168256748 cites W1569084902 @default.
- W2168256748 cites W1742137696 @default.
- W2168256748 cites W1932093217 @default.
- W2168256748 cites W1966336914 @default.
- W2168256748 cites W1969149505 @default.
- W2168256748 cites W1969368658 @default.
- W2168256748 cites W1982696728 @default.
- W2168256748 cites W1983141987 @default.
- W2168256748 cites W2000790912 @default.
- W2168256748 cites W2007194743 @default.
- W2168256748 cites W2012632994 @default.
- W2168256748 cites W2012973306 @default.
- W2168256748 cites W2021246324 @default.
- W2168256748 cites W2029356043 @default.
- W2168256748 cites W2032260378 @default.
- W2168256748 cites W2037021965 @default.
- W2168256748 cites W2040737548 @default.
- W2168256748 cites W2057448387 @default.
- W2168256748 cites W2069350424 @default.
- W2168256748 cites W2072799659 @default.
- W2168256748 cites W2074819347 @default.
- W2168256748 cites W2077026831 @default.
- W2168256748 cites W2077106285 @default.
- W2168256748 cites W2082803782 @default.
- W2168256748 cites W2083180635 @default.
- W2168256748 cites W2088922400 @default.
- W2168256748 cites W2103352453 @default.
- W2168256748 cites W2109163445 @default.
- W2168256748 cites W2111687706 @default.
- W2168256748 cites W2122116075 @default.
- W2168256748 cites W2128157888 @default.
- W2168256748 cites W2134414477 @default.
- W2168256748 cites W2135110328 @default.
- W2168256748 cites W2142179136 @default.
- W2168256748 cites W2143695755 @default.
- W2168256748 cites W2149849190 @default.
- W2168256748 cites W2154375899 @default.
- W2168256748 cites W2168015220 @default.
- W2168256748 cites W2169514045 @default.
- W2168256748 cites W2951339897 @default.
- W2168256748 doi "https://doi.org/10.1111/bjd.12118" @default.
- W2168256748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23110708" @default.
- W2168256748 hasPublicationYear "2013" @default.
- W2168256748 type Work @default.
- W2168256748 sameAs 2168256748 @default.
- W2168256748 citedByCount "65" @default.
- W2168256748 countsByYear W21682567482012 @default.
- W2168256748 countsByYear W21682567482013 @default.
- W2168256748 countsByYear W21682567482014 @default.
- W2168256748 countsByYear W21682567482015 @default.
- W2168256748 countsByYear W21682567482016 @default.
- W2168256748 countsByYear W21682567482017 @default.
- W2168256748 countsByYear W21682567482018 @default.
- W2168256748 countsByYear W21682567482019 @default.
- W2168256748 countsByYear W21682567482020 @default.
- W2168256748 countsByYear W21682567482021 @default.
- W2168256748 countsByYear W21682567482022 @default.
- W2168256748 countsByYear W21682567482023 @default.
- W2168256748 crossrefType "journal-article" @default.
- W2168256748 hasAuthorship W2168256748A5016818733 @default.
- W2168256748 hasAuthorship W2168256748A5042034018 @default.
- W2168256748 hasAuthorship W2168256748A5073522064 @default.
- W2168256748 hasAuthorship W2168256748A5080357338 @default.
- W2168256748 hasAuthorship W2168256748A5087192032 @default.
- W2168256748 hasAuthorship W2168256748A5090979652 @default.
- W2168256748 hasConcept C126322002 @default.
- W2168256748 hasConcept C16005928 @default.
- W2168256748 hasConcept C17991360 @default.
- W2168256748 hasConcept C194832188 @default.
- W2168256748 hasConcept C199901988 @default.
- W2168256748 hasConcept C2777138892 @default.
- W2168256748 hasConcept C2777391703 @default.
- W2168256748 hasConcept C2779306644 @default.
- W2168256748 hasConcept C2780564577 @default.
- W2168256748 hasConcept C3020604521 @default.
- W2168256748 hasConcept C71924100 @default.
- W2168256748 hasConcept C90924648 @default.
- W2168256748 hasConceptScore W2168256748C126322002 @default.
- W2168256748 hasConceptScore W2168256748C16005928 @default.
- W2168256748 hasConceptScore W2168256748C17991360 @default.
- W2168256748 hasConceptScore W2168256748C194832188 @default.
- W2168256748 hasConceptScore W2168256748C199901988 @default.
- W2168256748 hasConceptScore W2168256748C2777138892 @default.
- W2168256748 hasConceptScore W2168256748C2777391703 @default.
- W2168256748 hasConceptScore W2168256748C2779306644 @default.
- W2168256748 hasConceptScore W2168256748C2780564577 @default.
- W2168256748 hasConceptScore W2168256748C3020604521 @default.